Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.400 |
None |
0.943 |
53 |
4
|
2002 |
2020 |
Insulin resistance syndrome
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
62
|
15
|
0.060 |
None |
1.000 |
6 |
|
2002 |
2006 |
Coronary Restenosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
16
|
2
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.400 |
None |
0.989 |
89 |
4
|
2003 |
2020 |
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.100 |
None |
0.987 |
79 |
4
|
2003 |
2020 |
Polycystic Ovary Syndrome
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
988
|
363
|
0.100 |
None |
0.944 |
71 |
7
|
2003 |
2020 |
Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
620
|
64
|
0.300 |
None |
0.938 |
32 |
2
|
2003 |
2019 |
Hypoadiponectinemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
16
|
17
|
0.500 |
None |
1.000 |
25 |
10
|
2003 |
2019 |
Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
2723
|
2387
|
0.400 |
None |
0.957 |
23 |
4
|
2003 |
2020 |
Endothelial dysfunction
|
phenotype |
|
Disease or Syndrome
|
716
|
25
|
0.100 |
None |
1.000 |
20 |
|
2003 |
2019 |
Lipodystrophy
|
disease |
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
226
|
28
|
0.100 |
None |
1.000 |
16 |
|
2003 |
2019 |
Obesity, Morbid
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
203
|
49
|
0.100 |
None |
1.000 |
14 |
|
2003 |
2019 |
Nonalcoholic Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
434
|
17
|
0.380 |
None |
1.000 |
9 |
1
|
2003 |
2017 |
Inflammation
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
467
|
|
0.360 |
None |
1.000 |
7 |
|
2003 |
2009 |
Obesity, Visceral
|
phenotype |
Nutritional and Metabolic Diseases
|
Sign or Symptom
|
55
|
3
|
0.070 |
None |
1.000 |
7 |
|
2003 |
2019 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.060 |
None |
1.000 |
6 |
|
2003 |
2019 |
Myocardial Ischemia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
756
|
103
|
0.350 |
None |
0.833 |
6 |
|
2003 |
2019 |
Hyperemia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
64
|
3
|
0.320 |
None |
1.000 |
2 |
|
2003 |
2005 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.020 |
None |
1.000 |
2 |
1
|
2003 |
2014 |
HIV-Associated Lipodystrophy Syndrome
|
disease |
Nutritional and Metabolic Diseases; Infections; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
12
|
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2019 |
Bulimia Nervosa
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
71
|
24
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2017 |
Venous Engorgement
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Weight Gain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
124
|
12
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Active Hyperemia
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |